Cadena Research is a CRO created by CPDC to accelerate the development of radiopharmaceuticals. Cadena Research bridges a critical market gap in the rapidly expanding radiopharmaceutical industry by delivering comprehensive preclinical development support to innovators worldwide. The organization provides a suite of services including in vitro and in vivo research and development, screening, lead optimization, toxicology, dosimetry, imaging, and advanced radiochemistry capabilities. In addition, Cadena Research offers GLP capabilities for IND-enabling studies. Clients benefit from strategic advisory services offered by a team of experienced radiopharmaceutical professionals. Every project is managed from inception through to completion by a dedicated project manager, ensuring seamless communication and timely delivery.

Learn more here: Cadena Research